This invention relates to a novel carbazomide derivative salt having therapeutic effects for mental disorders, and its use. The compound of chemical formula 1 or a pharmaceutically acceptable salt thereof can treat or prevent mental disorders such as depression, anxiety disorders, panic disorders, obsessive-compulsive disorders, phobias, and attention deficit hyperactivity disorder. It can increase compliance, have minimal side effects, and have a therapeutic effect for mental disorders by effectively inhibiting the reuptake of serotonin, norepinephrine, or dopamine.
A series of 4-benzylpiperidine carboxamides were designed and synthesized, and tested for their dual (serotonin and norepinephrine) reuptake inhibition. The synthesis of 4-benzylpiperidine carboxamides involved two main steps: amidation and substitution. Derivatives with 3 carbon linker displayed better activity than with 2 carbon linker. 4-Biphenyl- and 2-naphthyl-substituted derivatives 7e and 7j showed greater dual reuptake inhibition than standard drug venlafaxine HCl. (C) 2015 Elsevier Ltd. All rights reserved.
Oxazolines. 3. Regioselective synthesis of 2-(monosubstituted phenyl) and/or unsymmetrically 2-(disubstituted phenyl) 2-oxazolines by cross-coupling Grignard reagents to (haloaryl)-2-oxazolines
作者:Lendon N. Pridgen
DOI:10.1021/jo00143a029
日期:1982.10
PRIDGEN, L. N., J. ORG. CHEM., 1982, 47, N 22, 4319-4323